Preferred Label : continuous erythropoietin receptor activator;

MeSH note : a third-generation erythropoietic molecule created by integrating a large polymer chain into the molecule, thus increasing the molecular weight to twice that of epoetin at approximately 60 kDa; the methoxy-polyethylene glycol polymer chain is integrated via amide bonds between the N-terminal amino group or the e-amino group of lysine (predominantly lysine-52 or lysine-45), using a single succinimidyl butanoic acid linker; an erythropoiesis-stimulating agent for the treatment of anemia;

MeSH synonym : CERA (erythropoietin receptor activator);

Related MeSH term : epoetin beta pegol;

Is substance : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3151135/fr/mircera
2020
false
true
false
France
methoxy polyethylene glycol-epoetin beta
methoxy polyethylene glycol-epoetin beta
hematinics
treatment outcome
insurance, health, reimbursement
anemia
renal insufficiency, chronic
adult
anemia of chronic renal failure
Anemia of chronic renal failure (disorder)
evaluation of the transparency committee
continuous erythropoietin receptor activator
polyethylene glycols
erythropoietin

---
http://www.has-sante.fr/portail/jcms/c_1647165/fr/anemie-chez-linsuffisant-renal-comment-utiliser-les-agents-stimulant-lerythropoiese-fiche-bum
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-09/fs_bum_epo_v5.pdf
2013
true
France
French
Darbepoetin alfa
Epoetin Alfa
anemia
renal insufficiency, chronic
guidelines for drug use
erythropoietin
recombinant proteins
hematinics
injections
erythropoietin
darbepoetin alfa
epoetin zeta
epoetin beta
epoetin theta
continuous erythropoietin receptor activator
methoxy polyethylene glycol-epoetin beta
anemia, iron-deficiency
continuity of patient care
erythropoietin
polyethylene glycols

---
https://www.ema.europa.eu/medicines/human/EPAR/Mircera
2012
United Kingdom
English
French
syndication feed
recombinant proteins
recombinant proteins
polyethylene glycols
anemia
polyethylene glycols
renal insufficiency, chronic
drug evaluation
treatment outcome
drug approval
drug labeling
adult
injections, intravenous
injections, subcutaneous
pregnancy
breast feeding
drug evaluation, preclinical
erythropoietin
erythropoietin
epoetin beta
monomethoxypolyethylene glycol
epoetin beta
monomethoxypolyethylene glycol
continuous erythropoietin receptor activator
continuous erythropoietin receptor activator
methoxy polyethylene glycol-epoetin beta
polyethylene glycols
drug evaluation
summary of product characteristics
package leaflet

---
http://www.meddispar.fr/medicaments/3903725
2009
France
French
continuous erythropoietin receptor activator
erythropoietin
polyethylene glycols
pharmaceutical solutions
injections, subcutaneous
injections, intravenous
drug prescriptions
legislation, drug
methoxy polyethylene glycol-epoetin beta
drug information

---
http://www.meddispar.fr/medicaments/3903808
2009
France
French
continuous erythropoietin receptor activator
erythropoietin
polyethylene glycols
pharmaceutical solutions
injections, subcutaneous
injections, intravenous
drug prescriptions
legislation, drug
methoxy polyethylene glycol-epoetin beta
drug information

---
http://www.meddispar.fr/medicaments/3903814
2009
France
French
continuous erythropoietin receptor activator
pharmaceutical solutions
injections, subcutaneous
injections, intravenous
drug prescriptions
legislation, drug
polyethylene glycols
erythropoietin
methoxy polyethylene glycol-epoetin beta
drug information

---
http://www.meddispar.fr/medicaments/3815151
2008
France
French
erythropoietin
polyethylene glycols
drug prescriptions
legislation, drug
injections
anemia
renal insufficiency, chronic
continuous erythropoietin receptor activator
methoxy polyethylene glycol-epoetin beta
drug information

---
http://www.meddispar.fr/medicaments/3815145
2008
France
French
erythropoietin
polyethylene glycols
injections
drug prescriptions
legislation, drug
anemia
renal insufficiency, chronic
continuous erythropoietin receptor activator
methoxy polyethylene glycol-epoetin beta
drug information

---
http://www.meddispar.fr/medicaments/3815180
2008
France
French
erythropoietin
legislation, drug
polyethylene glycols
drug prescriptions
injections
anemia
renal insufficiency, chronic
continuous erythropoietin receptor activator
methoxy polyethylene glycol-epoetin beta
drug information

---
http://www.meddispar.fr/medicaments/3815174
2008
France
French
drug prescriptions
legislation, drug
polyethylene glycols
anemia
renal insufficiency, chronic
erythropoietin
continuous erythropoietin receptor activator
methoxy polyethylene glycol-epoetin beta
drug information

---
http://www.meddispar.fr/medicaments/3815211
2008
France
French
erythropoietin
drug prescriptions
polyethylene glycols
legislation, drug
continuous erythropoietin receptor activator
methoxy polyethylene glycol-epoetin beta
drug information

---
https://www.cadth.ca/sites/default/files/pdf/E0025_Mircera_for_Renal_Anemia_cetap_f.pdf
https://www.cadth.ca/sites/default/files/pdf/E0025_Mircera_for_Renal_Anemia_cetap_e.pdf
2008
Canada
French
English
polyethylene glycols
erythropoietin
renal insufficiency, chronic
anemia
continuous erythropoietin receptor activator
methoxy polyethylene glycol-epoetin beta
polyethylene glycols
drug evaluation

---
http://www.meddispar.fr/medicaments/3815205
2008
France
French
polyethylene glycols
erythropoietin
drug prescriptions
legislation, drug
injections
anemia
renal insufficiency, chronic
continuous erythropoietin receptor activator
methoxy polyethylene glycol-epoetin beta
drug information

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.